Outer membrane vesicles derived fromE. colias novel vehicles for transdermal and tumor targeting delivery

Transdermal drug delivery is favored in clinical therapy because of its ability to overcome the shortcomings of the first pass elimination of the liver caused by traditional oral administration and the irreversibility of the injection.